Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)
Lecia Van Dam Sequist, A. Chiang, J. Gilbert et al. · Annals of Oncology · 2016
Cited by 41 works. doi:10.1093/annonc/mdw389.03 Open-access PDF